Literature DB >> 7470640

The value of prognostic indices in aplastic anaemia.

D T Sleijfer, N H Mulder, H O Nieweg.   

Abstract

In 43 patients with aplastic anaemia we assessed the accuracy of different prognostic systems. Patients dying within 6 months after diagnosis were correctly predicted in 60% of cases with the Lynch-index with a sensitivity of 82%. With the Najean-index 40% of these patients are correctly predicted, this index has a sensitivity of 100%. More accurate are the prognostic criteria proposed by Camitta et al [5]. With these criteria, this rapidly fatal group is correctly predicted in 85% of the patients, indicating that 15% of the patients are incorrectly predicted to have a limited survival. The sensitivity, however, is 100%. The Lohrmann-index, based on reticulocyte count predicts 64% of this group with severe aplasia. None of these prognostic systems do accurately predict long survival. We suggest that the best differentiation between patients with a long-term prognosis (more than 5 years) and patients who die from aplastic anaemia within 5 years, is made by re-evaluating the leucocyte and platelet count 3 months after the initial diagnosis. Decrease in blood counts (over 10%) predicts death from aplastic anaemia within 5 years correctly in all patients; stable or increased blood counts predict long survival in 75% of the patients.

Entities:  

Mesh:

Year:  1981        PMID: 7470640     DOI: 10.1007/bf01030028

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  26 in total

1.  Selection of patients for bone marrow transplantation in severe aplastic anemia.

Authors:  B M Camitta; J M Rappeport; R Parkman; D G Nathan
Journal:  Blood       Date:  1975-03       Impact factor: 22.113

2.  The prognosis in aplastic anemia.

Authors:  R E Lynch; D M Williams; J C Reading; G E Cartwright
Journal:  Blood       Date:  1975-04       Impact factor: 22.113

3.  COURSE AND PROGNOSIS IN APLASTIC ANAEMIA.

Authors:  S M LEWIS
Journal:  Br Med J       Date:  1965-04-17

4.  One-hundred-ten patients with aplastic anemia (AA) treated by marrow transplantation in Seattle.

Authors:  R Storb; E D Thomas; P L Weiden; C D Buckner; R A Clift; A Fefer; B W Goodell; F L Johnson; P E Neiman; J E Sanders; J Singer
Journal:  Transplant Proc       Date:  1978-03       Impact factor: 1.066

Review 5.  Quantitative radioisotope scanning and its use in haematology.

Authors:  C S Bowring
Journal:  Clin Haematol       Date:  1977-10

Review 6.  Drug-induced aplastic anemia.

Authors:  D M Williams; R E Lynch; G E Cartwright
Journal:  Semin Hematol       Date:  1973-07       Impact factor: 3.851

7.  [Acquired panmyelopathies].

Authors:  G Keiser
Journal:  Schweiz Med Wochenschr       Date:  1970-11-14

8.  Lithium therapy of aplastic anemia.

Authors:  S F Blum
Journal:  N Engl J Med       Date:  1979-03-22       Impact factor: 91.245

9.  Prognostic factors in acquired aplastic anemia. A study of 352 cases.

Authors:  Y Najean; A Pecking
Journal:  Am J Med       Date:  1979-10       Impact factor: 4.965

10.  Bone-marrow transplantation in severe aplastic anaemia.

Authors: 
Journal:  Lancet       Date:  1976-10-30       Impact factor: 79.321

View more
  1 in total

1.  Should we still use Camitta's criteria for severe aplastic anemia?

Authors:  Hyun Hwa Yoon; Seok Jae Huh; Ji Hyun Lee; Suee Lee; Sung-Hyun Kim; Hyuk Chan Kwon; Hyo-Jin Kim
Journal:  Korean J Hematol       Date:  2012-06-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.